EKSO – Ekso Bionics Holdings Inc.
EKSO — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
10.03
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
1.41
EPS Last/This Y
4.47
EPS This/Next Y
0.37
Price
10.12
Target Price
49.75
Analyst Recom
2
Performance Q
85.56
Upside
-1,844.8%
Beta
0.75
Ticker: EKSO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | EKSO | 10.06 | N/A | N/A | 0 |
| 2026-03-02 | EKSO | 10.01 | N/A | N/A | 0 |
| 2026-03-03 | EKSO | 10 | N/A | N/A | 0 |
| 2026-03-04 | EKSO | 10.79 | N/A | N/A | 0 |
| 2026-03-05 | EKSO | 10.83 | N/A | N/A | 0 |
| 2026-03-06 | EKSO | 11.38 | N/A | N/A | 0 |
| 2026-03-09 | EKSO | 12.02 | N/A | N/A | 0 |
| 2026-03-10 | EKSO | 12.4 | N/A | N/A | 0 |
| 2026-03-11 | EKSO | 12.75 | N/A | N/A | 0 |
| 2026-03-12 | EKSO | 11.75 | N/A | N/A | 0 |
| 2026-03-13 | EKSO | 11.81 | N/A | N/A | 0 |
| 2026-03-17 | EKSO | 10.79 | N/A | N/A | 0 |
| 2026-03-18 | EKSO | 10.51 | N/A | N/A | 0 |
| 2026-03-19 | EKSO | 10.4 | N/A | N/A | 0 |
| 2026-03-20 | EKSO | 10.56 | N/A | N/A | 0 |
| 2026-03-23 | EKSO | 10.56 | N/A | N/A | 0 |
| 2026-03-24 | EKSO | 10.48 | N/A | N/A | 0 |
| 2026-03-25 | EKSO | 10.9 | N/A | N/A | 0 |
| 2026-03-26 | EKSO | 10.87 | N/A | N/A | 0 |
| 2026-03-27 | EKSO | 10.18 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | EKSO | 10.16 | - | - | -0.43 |
| 2026-03-02 | EKSO | 10.22 | - | - | -0.43 |
| 2026-03-03 | EKSO | 10.01 | - | - | -0.43 |
| 2026-03-04 | EKSO | 10.80 | - | - | -0.43 |
| 2026-03-05 | EKSO | 10.98 | - | - | -0.43 |
| 2026-03-06 | EKSO | 11.43 | - | - | -0.43 |
| 2026-03-09 | EKSO | 12.02 | - | - | -0.43 |
| 2026-03-10 | EKSO | 12.40 | - | - | -0.43 |
| 2026-03-11 | EKSO | 12.69 | - | - | -0.43 |
| 2026-03-12 | EKSO | 11.89 | - | - | -0.43 |
| 2026-03-13 | EKSO | 11.51 | - | - | -0.43 |
| 2026-03-17 | EKSO | 10.91 | - | - | -0.43 |
| 2026-03-18 | EKSO | 10.55 | - | - | -0.43 |
| 2026-03-19 | EKSO | 10.50 | - | - | -0.43 |
| 2026-03-20 | EKSO | 10.50 | - | - | -0.43 |
| 2026-03-23 | EKSO | 10.70 | - | - | -0.43 |
| 2026-03-24 | EKSO | 10.74 | - | - | -0.43 |
| 2026-03-25 | EKSO | 10.99 | - | - | -0.43 |
| 2026-03-26 | EKSO | 10.99 | - | - | -0.43 |
| 2026-03-27 | EKSO | 10.12 | - | - | -0.43 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | EKSO | 8.72 | -21.18 | 10.46 |
| 2026-03-02 | EKSO | 8.72 | -0.45 | 10.46 |
| 2026-03-03 | EKSO | 8.72 | -0.45 | 10.46 |
| 2026-03-04 | EKSO | 8.72 | -0.45 | 10.46 |
| 2026-03-05 | EKSO | 8.72 | -0.45 | 10.46 |
| 2026-03-06 | EKSO | 8.71 | -0.45 | 10.46 |
| 2026-03-09 | EKSO | 8.72 | -0.45 | 10.46 |
| 2026-03-10 | EKSO | 8.72 | -0.45 | 10.46 |
| 2026-03-11 | EKSO | 8.72 | -0.45 | 9.29 |
| 2026-03-12 | EKSO | 8.71 | -0.45 | 9.29 |
| 2026-03-13 | EKSO | 8.72 | -0.45 | 9.29 |
| 2026-03-17 | EKSO | 8.72 | -0.45 | 9.29 |
| 2026-03-18 | EKSO | 8.72 | -0.45 | 9.29 |
| 2026-03-19 | EKSO | 8.72 | -0.45 | 9.29 |
| 2026-03-20 | EKSO | 8.72 | -0.45 | 9.29 |
| 2026-03-23 | EKSO | 9.06 | -0.47 | 9.29 |
| 2026-03-24 | EKSO | 9.06 | -0.47 | 9.29 |
| 2026-03-25 | EKSO | 9.06 | -0.47 | 10.03 |
| 2026-03-26 | EKSO | 9.06 | -0.47 | 10.03 |
| 2026-03-27 | EKSO | 9.06 | -0.47 | 10.03 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.56
Avg. EPS Est. Current Quarter
-0.23
Avg. EPS Est. Next Quarter
-0.15
Insider Transactions
9.06
Institutional Transactions
-0.47
Beta
0.75
Average Sales Estimate Current Quarter
4
Average Sales Estimate Next Quarter
4
Fair Value
Quality Score
34
Growth Score
32
Sentiment Score
84
Actual DrawDown %
90.6
Max Drawdown 5-Year %
-97.3
Target Price
49.75
P/E
Forward P/E
PEG
P/S
2.83
P/B
4
P/Free Cash Flow
EPS
-5.06
Average EPS Est. Cur. Y
-0.43
EPS Next Y. (Est.)
-0.07
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-91.37
Relative Volume
0.02
Return on Equity vs Sector %
-156.9
Return on Equity vs Industry %
-139.1
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
EKSO
Healthcare
$10.15
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
45.1
Range 1M
3.7%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
89.6%
EPS NY
88.2%
52W%
67.5%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+390.1% upside
Upside
+390.1%
Quality
34
Ekso Bionics Holdings, Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 50
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
EKSO
Latest News
—
Caricamento notizie per EKSO…
stock quote shares EKSO – Ekso Bionics Holdings Inc. Stock Price stock today
news today EKSO – Ekso Bionics Holdings Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EKSO – Ekso Bionics Holdings Inc. yahoo finance google finance
stock history EKSO – Ekso Bionics Holdings Inc. invest stock market
stock prices EKSO premarket after hours
ticker EKSO fair value insiders trading